ARCHIVES

Phase III BETH Study Combining Avastin And Herceptin Open For Enrollment

This article is from The Cancer Letter archive.

Vol. 31 No. 6 | June 27, 2008

Download PDF Visit The Full Archive

Related Articles

Bush Budget Stresses Research Now, Public Health Interventions Later.

April 13, 2001

In Brief: Wyeth-Ayerst To donate hormone Replacement Therapy To NIH For Women’s Health Initiative

April 23, 1993

Efaproxyn Improved Survival Of Patients With Brain Mets

October 29, 2004

NCI, SAIC To Support Contracts For Molecular Target Labs.

February 25, 2000

New ACS Awards Total $18.4 Million

February 23, 1979

In Brief: Gene Therapy For ADA Deficiency Moves forward With Stem Cell Treatment In Caif. And At NIH

June 18, 1993